News Focus
News Focus
Followers 15
Posts 151
Boards Moderated 0
Alias Born 06/20/2020

Re: None

Tuesday, 01/26/2021 9:03:51 AM

Tuesday, January 26, 2021 9:03:51 AM

Post# of 174
Breaking News Hits Wire! SILO Announces Reaches Terms with
University of Maryland Baltimore for Exclusive License of Central Nervous Homing Peptide for Neuroinflammatory Disease

Dear Fellow Trader,

Immediately turn your attention to Silo Pharma Inc. (SILO)

SILO just released news today it has exercised its option to take an exclusive license for patents owned by the University of Maryland Baltimore for the treatment of Neuroinflammatory Disease.

News Link Here - snapshot below

JANUARY 26, 2021

Silo Pharma Reaches Terms with University of Maryland Baltimore for Exclusive License of Central Nervous Homing Peptide for Neuroinflammatory Disease

Englewood Cliffs, NJ, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson’s, and other rare neurological disorders, announced today it has exercised its option to take an exclusive license for patents owned by the University of Maryland Baltimore for the treatment of Neuroinflammatory Disease.

The exercise of the option agreement allows for Silo to negotiate an exclusive patent license agreement. The option agreement included pre-negotiated business terms for the exclusive patent license, which we expect to finalize shortly.

Mr. Eric Weisblum, Chairman and CEO of Silo Pharma, commented, “Silo is pleased to advance our research collaboration with UMB in the fight against Neuroinflammatory diseases. We are focused on the development of this novel therapeutic targeting those who have been afflicted with CNS inflammatory diseases. Management looks forward to sharing the preclinical results of this Novel Homing Peptide upon completion of our initial study in connection with UMB."

If you haven't yet read SILO full profile, do so HERE

Click here to get the full Report!

This could be the beginning of a Massive Short Squeeze and has the Potential to Send Shares Soaring Much Much Higher.

As you know, a “Short Squeeze” is a Stock Market Phenom that can send shares of a stock Dramatically Higher in a short period of time—generally anywhere from a few hours to a few days. Any stock is susceptible to a short squeeze, but those with low volume are especially vulnerable.

...Now take a look at the Short Report on SILO:

Image

Last Thursday, 60.34% of the volume was Short… then on Friday an astounding 65.12% of SILO’s volume was Short... Then yesterday 61.29% of the volume was Short.

These Shorts will have to cover and this could potentially cause a Short Squeeze and send shares of SILO Soaring…

You do not want to miss out on SILO… especially if we see signs of a Short Squeeze about to Send Shares Soaring.

If you haven't taken a look at this stock yet, this is your chance. Make sure you have SILO pulled up on your trading screen.

Sincerely,
Editor In Chief, OTCtipReporter Team
[url]
https://www.otctipreporter.com/[/url][tag]insert-text-here[/tag]
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SILO News